These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 9737829

  • 21. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 22. Exenatide: a review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea).
    Cvetković RS, Plosker GL.
    Drugs; 2007 Nov; 67(6):935-54. PubMed ID: 17428109
    [Abstract] [Full Text] [Related]

  • 23. Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy.
    Biondi-Zoccai G, Pinto A, Versaci F, Procaccini E, Neri G, Sesti G, Uccioli L, Vetere M, Peruzzi M, Nudi F.
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):162-70. PubMed ID: 27074768
    [Abstract] [Full Text] [Related]

  • 24. The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.
    Jil M, Rajnikant M, Richard D, Iskandar I.
    Diab Vasc Dis Res; 2017 Jul; 14(4):295-303. PubMed ID: 28330386
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors as add-on to metformin and sulfonylurea treatment for the management of type 2 diabetes: a meta-analysis.
    Li J, Shao YH, Wang XG, Gong Y, Li C, Lu Y.
    Endocr J; 2018 Mar 28; 65(3):335-344. PubMed ID: 29375082
    [Abstract] [Full Text] [Related]

  • 26. Complementing insulin therapy to achieve glycemic control.
    Barnett AH.
    Adv Ther; 2013 Jun 28; 30(6):557-76. PubMed ID: 23797471
    [Abstract] [Full Text] [Related]

  • 27. Retrospective chart review of children with type 2 diabetes mellitus evaluating the efficacy of metformin vs. insulin vs. combination insulin/metformin.
    Meyer SL, Hoffman RP.
    South Med J; 2011 Oct 28; 104(10):684-8. PubMed ID: 21941156
    [Abstract] [Full Text] [Related]

  • 28. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Groop L, Widén E.
    Diabete Metab; 1991 May 28; 17(1 Pt 2):218-23. PubMed ID: 1936480
    [Abstract] [Full Text] [Related]

  • 29. Impact of concomitant oral glucose-lowering medications on the success of basal insulin titration in insulin-naïve patients with type 2 diabetes: a systematic analysis.
    Wollenhaupt D, Wolters J, Abd El Aziz M, Nauck MA.
    BMJ Open Diabetes Res Care; 2023 Jul 28; 11(4):. PubMed ID: 37433696
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial.
    Aroda VR, Bain SC, Cariou B, Piletič M, Rose L, Axelsen M, Rowe E, DeVries JH.
    Lancet Diabetes Endocrinol; 2017 May 28; 5(5):355-366. PubMed ID: 28344112
    [Abstract] [Full Text] [Related]

  • 31. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
    Drzewoski J, Czupryniak L.
    Med Sci Monit; 2003 Jun 28; 9(6):CR240-3. PubMed ID: 12824953
    [Abstract] [Full Text] [Related]

  • 32. The effects of combined insulin and metformin therapy in obese patients with diabetes mellitus type 2 in the early stage of the disease.
    Ascić-Buturović B.
    Bosn J Basic Med Sci; 2006 May 28; 6(2):54-8. PubMed ID: 16879115
    [Abstract] [Full Text] [Related]

  • 33. Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial.
    Lee SE, Choi Y, Jun JE, Lee YB, Jin SM, Hur KY, Ko GP, Lee MK.
    Diabetes Metab J; 2019 Aug 28; 43(4):422-431. PubMed ID: 31237126
    [Abstract] [Full Text] [Related]

  • 34. [The effects of metformin plus sulfonylurea therapy on clinical features of the metabolic syndrome].
    Koprivica B, Beljić-Zivković T, Ille T.
    Med Pregl; 2010 Aug 28; 63(9-10):611-5. PubMed ID: 21446088
    [Abstract] [Full Text] [Related]

  • 35. Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.
    Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, Rawdaree P, Plengvidhya N, Leelawatana R, Bunnag P, Pratipanawatr T, Krittiyawong S, Suwanwalaikorn S, Deerochanawong C, Chetthakul T, Ngarmukos C, Komoltri C.
    J Med Assoc Thai; 2006 Aug 28; 89 Suppl 1():S66-71. PubMed ID: 17715836
    [Abstract] [Full Text] [Related]

  • 36. 10-year follow-up of intensive glucose control in type 2 diabetes.
    Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.
    N Engl J Med; 2008 Oct 09; 359(15):1577-89. PubMed ID: 18784090
    [Abstract] [Full Text] [Related]

  • 37. Glycemic response to newly initiated diabetes therapies.
    Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Go AS, Selby JV.
    Am J Manag Care; 2007 Nov 09; 13(11):598-606. PubMed ID: 17988185
    [Abstract] [Full Text] [Related]

  • 38. Intentional weight loss and dose reductions of anti-diabetic medications--a retrospective cohort study.
    Kumar AA, Palamaner Subash Shantha G, Kahan S, Samson RJ, Boddu ND, Cheskin LJ.
    PLoS One; 2012 Nov 09; 7(2):e32395. PubMed ID: 22384240
    [Abstract] [Full Text] [Related]

  • 39. Monitoring safety and effectiveness in patients receiving metformin.
    Choe HM, Cornish L, Townsend K, Jobe J, Mitrovich S.
    Am J Health Syst Pharm; 2004 Aug 01; 61(15):1550-1. PubMed ID: 15372824
    [No Abstract] [Full Text] [Related]

  • 40. Predictors of insulin initiation in metformin and sulfonylurea users in primary care practices: the role of kidney function.
    Kostev K, Dippel FW, Rathmann W.
    J Diabetes Sci Technol; 2014 Sep 01; 8(5):1023-8. PubMed ID: 24876433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.